M Sterneck
Overview
Explore the profile of M Sterneck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Galante A, Pischke S, Polywka S, Luetgehethmann M, Suneetha P, Gisa A, et al.
Transpl Infect Dis
. 2015 Jun;
17(4):617-22.
PMID: 26094550
The chronic course of hepatitis E virus (HEV) infections in orthotopic liver transplant (OLT) recipients has been described previously, but prospectively collected data are rare. We aimed to study the...
12.
Kramer K, Thye T, Treszl A, Peine S, Koch M, Sterneck M, et al.
Tissue Antigens
. 2014 Aug;
84(4):370-7.
PMID: 25112903
The nuclear factor of kappa light polypeptide gene enhancer B-cells inhibitor-alpha (NFKBIA) gene encodes a member of the nuclear factor-kappa-B inhibitor family. Polymorphisms in this gene might be associated with...
13.
Sterneck M, Settmacher U, Ganten T, Sarrazin C, Speidel N, Broering D, et al.
Transplant Proc
. 2014 Feb;
46(1):234-40.
PMID: 24507058
Objective: To evaluate improvement in gastrointestinal (GI) symptoms and health-related quality of life (HRQoL) in liver transplant recipients switched from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS). Methods: A...
14.
Sterneck M, Kaiser G, Heyne N, Richter N, Rauchfuss F, Pascher A, et al.
Am J Transplant
. 2014 Feb;
14(3):701-10.
PMID: 24502384
The feasibility of de novo everolimus without calcineurin inhibitor (CNI) therapy following liver transplantation was assessed in a multicenter, prospective, open-label trial. Liver transplant patients were randomized at 4 weeks...
15.
Thude H, Schipler A, Treszl A, Sterneck M, Nashan B
Int J Immunogenet
. 2012 Apr;
39(5):437-41.
PMID: 22524693
This study was carried out to evaluate the association between 77C>G transversion (rs17612648) in exon A of the PTPRC gene and liver transplant rejection. No significant differences in genotype and...
16.
Fischer L, Klempnauer J, Beckebaum S, Metselaar H, Neuhaus P, Schemmer P, et al.
Am J Transplant
. 2012 Apr;
12(7):1855-65.
PMID: 22494671
Posttransplant immunosuppression with calcineurin inhibitors (CNIs) is associated with impaired renal function, while mTor inhibitors such as everolimus may provide a renal-sparing alternative. In this randomized 1-year study in patients...
17.
Zollner B, Sterneck M, Wursthorn K, Petersen J, Schroter M, Laufs R, et al.
J Clin Microbiol
. 2005 May;
43(5):2503-5.
PMID: 15872296
The reverse transcriptase V207I mutation within the hepatitis B virus (HBV) polymerase is associated with resistance to lamivudine in vitro. The prevalence of this mutation in treatment-naive patients was 1%...
18.
Fischer L, Sterneck M
Mycoses
. 2005 Apr;
48 Suppl 1:27-35.
PMID: 15826284
Advances in surgical technique, immunosuppression, and medical management have greatly improved clinical results after liver transplantation (LTx). Fungal infections in LTx-patients still represent serious complications and are associated with a...
19.
Broering D, Bok P, Fischer L, Sterneck M, Rogiers X
Chirurg
. 2003 Nov;
74(10):951-7.
PMID: 14605738
Introduction: The increasing shortage of cadaveric organs makes living-related liver transplantation a more and more important option. Safety for the donor has the highest priority, and therefore detailed and thorough...
20.
Sterneck M, Zadeh K, Groteluschen R, Broring D, Rogiers X, Fischer L
Transplant Proc
. 2002 Dec;
34(8):3304-6.
PMID: 12493454
No abstract available.